Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Special programs for high school and undergraduate students at the AACR Annual Meeting provide valuable opportunities for learning, networking,...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.